Inventor · disambiguated record
Jiasheng Lu
Also filed as: LU JIASHENG
17 granted patents·13 pending applications·23 citations·filing 2014–2025
90Inventor score
Top patents by PatentIndex Score
30 records- 0192US11970490B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Apr 30, 2024·4 cites·24 claims
- 0289US11608314B2Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Mar 21, 2023·2 cites·16 claims
- 0389US11225497B2Prodrugs of a CDK inhibitor for treating cancersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Granted Jan 18, 2022·2 cites·16 claims
- 0489US10954188B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Mar 23, 2021·4 cites·17 claims
- 0585US12459888B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2024·Granted Nov 4, 2025·0 cites·3 claims
- 0685US10472323B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2017·Granted Nov 12, 2019·5 cites·20 claims
- 0784US11186543B2Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Nov 30, 2021·2 cites·24 claims
- 0884US2025353870A1Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
- 0982US11530234B2CD73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Granted Dec 20, 2022·1 cites·21 claims
- 1079US12312378B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 1177US2023295079A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
- 1276US10881681B2CD73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Jan 5, 2021·2 cites·21 claims
- 1375US11725020B2Prodrugs of a CDK inhibitor for treating cancersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Aug 15, 2023·0 cites·20 claims
- 1471US2025352516A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular diseaseRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
- 1569US2025109100A1Crystalline form of 3- ((l-valyl) amino) -i-propanesulfonic acidRISEN SUZHOU PHARMA TECH CO LTD·Filed 2024·Application pending·0 cites
- 1669US2025170161A1Inhibin subunit beta e inhibitor and methods of use thereofRISEN SHANGHAI MEDICINAL TECH CO LTD·Filed 2024·Application pending·0 cites
- 1769US2021347731A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 1868US12365675B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Jul 22, 2025·0 cites·20 claims
- 1966US12403129B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular diseaseRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Sep 2, 2025·0 cites·2 claims
- 2062US11591358B2Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Feb 28, 2023·0 cites·15 claims
- 2162US10301328B2Organoboron compounds and methods of making sameLU JIASHENG·Filed 2014·Granted May 28, 2019·1 cites·18 claims
- 2262US2024246963A1Bifunctional compounds and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 2361US2024239813A1Kras inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 2459US2024116952A1Kras inhibitor and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 2558US2023295213A1Cd73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
- 2658US2024279265A1Crystal forms of glucosamine derivative, and preparation method therefor and use thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
- 2755US12338205B2Crystalline form of 3-((L-valyl) amino)-1-propanesulfonic acidRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Jun 24, 2025·0 cites·20 claims
- 2854US2024024346A1Cd73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 2950US2021078970A1Prodrugs of the tyrosine kinase inhibitor for treating cancerRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Application pending·0 cites
- 3043US11718636B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Aug 8, 2023·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Jiasheng Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →